Clinuvel Pharmaceuticals Ltd (CLVLY)
9.040
+0.09
(+1.00%)
USD |
OTCM |
Nov 14, 15:17
Clinuvel Pharmaceuticals Enterprise Value: 325.30M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 325.30M |
| November 12, 2024 | 324.80M |
| November 11, 2024 | 324.80M |
| November 08, 2024 | 324.65M |
| November 07, 2024 | 338.07M |
| November 06, 2024 | 326.58M |
| November 05, 2024 | 326.55M |
| November 04, 2024 | 336.57M |
| November 01, 2024 | 341.32M |
| October 31, 2024 | 354.39M |
| October 30, 2024 | 354.39M |
| October 29, 2024 | 345.33M |
| October 28, 2024 | 345.33M |
| October 25, 2024 | 343.58M |
| October 24, 2024 | 320.29M |
| October 23, 2024 | 346.33M |
| October 22, 2024 | 345.33M |
| October 21, 2024 | 345.33M |
| October 18, 2024 | 345.33M |
| October 17, 2024 | 350.34M |
| October 16, 2024 | 365.36M |
| October 15, 2024 | 365.36M |
| October 14, 2024 | 365.36M |
| October 11, 2024 | 352.84M |
| October 10, 2024 | 361.35M |
| Date | Value |
|---|---|
| October 09, 2024 | 345.33M |
| October 08, 2024 | 345.33M |
| October 07, 2024 | 386.89M |
| October 04, 2024 | 386.89M |
| October 03, 2024 | 363.61M |
| October 02, 2024 | 367.86M |
| October 01, 2024 | 367.86M |
| September 30, 2024 | 352.84M |
| September 27, 2024 | 352.84M |
| September 26, 2024 | 352.84M |
| September 25, 2024 | 377.88M |
| September 24, 2024 | 377.88M |
| September 23, 2024 | 377.88M |
| September 20, 2024 | 375.63M |
| September 19, 2024 | 375.63M |
| September 18, 2024 | 367.11M |
| September 17, 2024 | 383.89M |
| September 16, 2024 | 377.88M |
| September 13, 2024 | 377.88M |
| September 12, 2024 | 372.87M |
| September 11, 2024 | 370.37M |
| September 10, 2024 | 360.35M |
| September 09, 2024 | 365.36M |
| September 06, 2024 | 349.09M |
| September 05, 2024 | 349.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
298.76M
Minimum
Aug 05 2024
1.484B
Maximum
Sep 23 2021
661.87M
Average
608.40M
Median
Enterprise Value Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | -- |
| Immutep Ltd | -- |
| Opthea Ltd | 544.62M |
| Mesoblast Ltd | -- |
Enterprise Value Related Metrics
| Earnings Yield | 5.07% |
| Operating Earnings Yield | 6.83% |
| Normalized Earnings Yield | 5.071 |